Halozyme Therapeutics shares owned by Hillsdale Investment Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Hillsdale Investment Management
from 13F filings
Historical chart of Hillsdale Investment Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Hillsdale Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Hillsdale Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $6.1M | 106k | 57.24 |
| 2024-06-30 | $5.7M | 108k | 52.36 |
| 2024-03-31 | $4.6M | 113k | 40.68 |
| 2021-03-31 | $3.2M | 78k | 41.65 |
| 2020-12-31 | $3.3M | 77k | 42.75 |
| 2019-12-31 | $768k | 43k | 17.74 |
| 2019-09-30 | $765k | 49k | 15.52 |
More positions owned by Hillsdale Investment Management
View all positions for Hillsdale Investment Management